Aptahem AB Stock

Stocks

End-of-day quote NORDIC GROWTH MARKET Other stock markets 2026-08-04			5-day change	1st Jan Change
0.5600 ^SEK	-10.26%		-16.17%	-51.09%

06-17	Aptahem Improves Quality And Manufacturing Efficiency In A New Apta-1 Test Batch	CI
06-17	Aptahem Reports Improved Production of Apta-1	FW

06-17	Aptahem Improves Quality And Manufacturing Efficiency In A New Apta-1 Test Batch	CI
06-17	Aptahem Reports Improved Production of Apta-1	FW
05-28	Aptahem AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-28	Aptahem reports narrowed operating loss	FW
05-11	Aptahem to focus on conditions mirroring sepsis pathology - newsletter	FW
04-28	Aptahem finalizes rights issue results - subscribed to 23.7 percent	FW
04-24	Aptahem raises SEK 3.3 million in undersubscribed rights issue - preliminary figures	FW
04-07	Aptahem shares trade ex-rights on Spotlight today following rights issue	FW
03-27	Aptahem announces rights issue of approximately SEK 13.8 million	FW
02-26	Aptahem AB Auditor Raises 'Going Concern' Doubt	CI
02-25	Aptahem Proposes Election of Brian Packard to the Board	FW
02-12	Aptahem Reports Minor Changes in Results – Data Room Activity at Record High	FW
02-12	Aptahem AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI

25-09-19

06-22	Aptahem: Newsletter June 2026	PU
06-22	Newsletter June 2026	AQ
06-17	Aptahem: Aptahem Improves Quality and Manufacturing Efficiency in a New Apta-1 Test Batch	PU
06-17	Aptahem Improves Quality and Manufacturing Efficiency in a New Apta-1 Test Batch	AQ
06-05	Aptahem: Aptahem to Participate at IOPC 2026 in Athens	PU

Manager	Title	Age	Since
Luiza Jedlina CTO	Chief Tech/Sci/R&D Officer	-	2016-02-29
Knut Mikael Ingolf Lindstam CEO	Chief Executive Officer	60	2013-12-31
Ola Skanung DFI	Director of Finance/CFO	62	-

Director	Title	Age	Since
Knut Mikael Ingolf Lindstam BRD	Director/Board Member	60	2013-12-31
Johan Lindh BRD	Director/Board Member	-	-
Ulla Cristina Glad BRD	Director/Board Member	74	2016-05-31

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
APTAHEM AB	-10.26%	-16.17%	-51.30%	-97.57%	1.52M
WUXI APPTEC CO., LTD.	+10.00%	+14.90%	+53.89%	+87.07%	62.53B
ARGENX SE	+1.48%	-4.74%	+23.34%	+67.11%	52.43B
BIONTECH SE	-0.98%	-1.19%	-16.98%	-14.21%	23.1B
INSMED INCORPORATED	+0.30%	-5.17%	-11.23%	+349.07%	21.4B
GENMAB A/S	-0.17%	+0.19%	+30.71%	-26.39%	17.76B
PHARMAESSENTIA CORPORATION	+4.29%	+8.97%	+200.03%	+341.85%	15.47B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+2.08%	-1.17%	+13.58%	+612.75%	14.68B
EXELIXIS, INC.	+1.71%	-0.90%	+52.13%	+176.27%	14.08B
ARROWHEAD PHARMACEUTICALS, INC.	+4.16%	+4.44%	+444.12%	+183.06%	12.62B
Average	+1.26%	-0.68%	+73.83%	+167.90%	23.41B
Weighted average by Cap.	+3.66%	+1.83%	+60.40%	+148.30%